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The major active retinoid, all-trans retinoic acid, has long been recognized as critical for the development of sev-
eral organs, including the eye. Mutations in STRA6, the gene encoding the cellular receptor for vitamin A, in
patients with Matthew–Wood syndrome and anophthalmia/microphthalmia (A/M), have previously demon-
strated the importance of retinol metabolism in human eye disease. We used homozygosity mapping combined
with next-generation sequencing to interrogate patients with anophthalmia and microphthalmia for new causa-
tive genes. We used whole-exome and whole-genome sequencing to study a family with two affected brothers
with bilateral A/M and a simplex case with bilateral anophthalmia and hypoplasia of the optic nerve and optic
chiasm. Analysis of novel sequence variants revealed homozygosity for two nonsense mutations in
ALDH1A3, c.568A>G, predicting p.Lys190∗, in the familial cases, and c.1165A>T, predicting p.Lys389∗, in the
simplex case. Both mutations predict nonsense-mediated decay and complete loss of function. We performed
antisense morpholino (MO) studies in Danio rerio to characterize the developmental effects of loss of Aldh1a3
function. MO-injected larvae showed a significant reduction in eye size, and aberrant axonal projections to
the tectum were noted. We conclude that ALDH1A3 loss of function causes anophthalmia and aberrant eye de-
velopment in humans and in animal model systems.
INTRODUCTION
Retinoic acid (RA) metabolism is vital for normal morphogenesis
(reviewed in 1,2). In mammals, retinol is bound to Retinol-binding
protein 4 (RBP4) and enters the cell by binding to Stimulated by
Retinoic Acid Gene 6 homologue (STRA6) transmembrane
protein (3). After entry into the cytoplasm, retinol is oxidized to
retinaldehyde by alcohol dehydrogenases and then converted
to RA by three retinaldehyde dehydrogenases—Aldehyde
dehydrogenase 1 family, member A1 (ALDH1A1), Aldehyde
dehydrogenase 1 family, member A2 (ALDH1A2) and
Aldehyde dehydrogenase 1 family, member A3 (ALDH1A3)
(1,2,4). RA can then bind to two classes of nuclear receptors—
the RA receptors (RARs) and the retinoid X receptors (RXRs),
to effect downstream gene signaling. RA binds as all-trans RA
(atRA) and 9cis-RA to the RAR a, b and g receptors and as
9cis-RA to the RXR a, b and g receptors (5).
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Compelling evidence that RA signaling is critical for eye
development has been gained from perturbations of most of
the steps of retinol metabolism outlined earlier (2). Deficien-
cies of vitamin A have been associated with coloboma in
humans and mice (6,7). Mutations in STRA6 have been
demonstrated in patients with isolated anophthalmia (8,9)
and in patients with Matthew–Wood syndrome (MIM
601186), also known as Pulmonary hypoplasia-Diaphragmat-
ic hernia-Anophthalmia-Cardiac defects (PDAC) syndrome
(10–12), and in patients with intermediate phenotypes (13).
Mice with deficiencies of RARs and RXRs studied by cross-
ing double-homozygous null mutants show variable ocular
defects similar to those observed with vitamin A or RA de-
ficiency, including coloboma, absence of the optic nerve,
shortening of the ventral retina and malformation of the an-
terior segment of the eye (5).
Anophthalmia (absent eyes), microphthalmia (small eyes)
and coloboma (defective closure of the optic fissure) are birth
defects that can be devastating because of the resultant lack of
vision. Currently, ,50% of patients with anophthalmia/micro-
phthalmia (A/M) and coloboma receive a molecular genetic
diagnosis after available investigations to determine the cause
of their birth defect. The major causative gene to date, SOX2,
is mutated in 10–20% of patients (14,15), and the remaining
known pathogenic genes are mutated in only a small number
of individuals (16–20). Chromosome aberrations are identified
in as many as 25–30% of individuals with eye malformations
(21,22), but are less commonly observed in A/M. As part of
ongoing research to determine new causative genes in patients
with A/M, we performed whole-exome and whole-genome se-
quencing in three patients with bilateral A/M, two from the
same family and one isolated case. Our results implicate
ALDH1A3 in the pathogenesis of the eye malformations, with
further implications for the role of RA signaling in human eye
development.
RESULTS
Case reports
Patients were diagnosed with A/M according to published
clinical criteria (17). We report clinical features of three chil-
dren with A/M, comprising two brothers (for pedigree, see
Fig. 1A) from an Egyptian cohort of anophthalmia patients
and one simplex case ascertained from the International Chil-
dren’s Anophthalmia Network (http://www.anophthalmia.org/
general_information.shtml). The first affected boy, III-3, was
an 11-year old male who presented with bilateral anophthal-
mia. His examination showed absent eyes with whitened con-
junctivae, short palpebral fissures and bilateral entropion.
Transpalpebral ultrasonography confirmed total anophthalmia
of both eyes and no cysts were observed (Figs 1C and D). He
had normal development and attended a regular school. His
affected younger brother, III-6, was 1 year of age and had
right-sided anophthalmia and severe microphthalmia of the
left eye. Physical examination showed an absent right eye,
very small and barely visible left eye and short palpebral fis-
sures with bilateral entropion similar to his brother. Transpal-
pebral ultrasonography showed total absence of the right eye
(Fig. 1E) and a very small globe with posterior coloboma,
detached retina and the presence of the optic nerve in the
left orbit (Fig. 1F). Both boys were born full term after
uneventful pregnancies and uncomplicated deliveries and
neither had additional phenotypic abnormalities or health
problems. Their parents and grandparents were unaffected
and the brothers had four siblings who were normal on com-
plete eye examination, but the parents refused venipuncture
for the unaffected children. Ethnicity was Egyptian and al-
though the family had no known history of consanguinity,
both parents originated from a rural region southwest of
Cairo.
The third patient was a 4-year-and-6-month-old female of
Hispanic ethnicity (Fig. 2A). She was born by vertex vaginal de-
livery at full term with a birthweight of 3030 g (25–50th centile).
At birth, she was noted to have anophthalmia that resulted in the
placement of conformers for orbital expansion. She passed her
newborn hearing screen. A cranial magnetic resonance
imaging scan of the head and orbits at 6 months of age identified
bilateral agenesis of the ocular globes with small optic nerves
and a small optic chiasm, but was otherwise unremarkable.
TORCH titers were normal. A real-time ultrasound scan of the
abdomen was reported as normal, although the kidneys
showed slight echogenicity bilaterally. At 5 months, her
weight was 7.14 kg (50–75th centile), height 63.75 cm (50–
75th centile) and head circumference 40 cm (10th centile). Her
development and general health were normal and there were
no significant examination findings apart from the eye abnormal-
ities and hyperkeratosis of the skin. She had a full brother and a
paternal half-brother, who were both healthy and there was no
history of ocular abnormalities in other family members. Her
parents were first cousins. Previous genetic testing included a
bacterial artificial chromosome microarray, clinical testing for
SOX2 mutations and research testing for OTX2, BMP4,
CHX10, PITX2 and FOXE3 mutations (14–19), all of which
were unrevealing.
Exome sequencing
Exome sequencing was performed in the two brothers (Supple-
mentary Material, Table S1). A total of 190 973 and 181 233 se-
quence variants were identified in the older and younger boy,
respectively (Supplementary Table S1). Examination of homo-
zygous, coding, non-synonymous or frameshift mutations in
homozygous regions shared by the affected brothers that were
not present in their parents showed only one common mutation
that was validated by Sanger sequencing: c.568A.G, predicting
p.Lys190∗, a nonsense mutation in ALDH1A3 (Fig. 1B; tran-
script NM_000693.2). This gene was located in the longest,
4.5 Mb region of homozygosity on chromosome 15 (Supple-
mentary Table S2). The p.Lys190∗ mutation was not observed
on Sanger sequencing of 92 chromosomes from healthy indivi-
duals stated to be of Egyptian origin and 384 chromosomes
from healthy individuals stated to be of European origin (data
not shown).
In the simplex case, genotyping showed several large regions
of loss of heterozygosity (assumed to be regions of autozygosity;
data not shown) and we analyzed novel sequence variants
detected by whole-genome sequencing in these regions. Cover-
age was excellent (average 50–60× across the genome; data not
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shown) and sequence variants were filtered out using the follow-
ing scheme:
(i) variants in regions of homozygosity—1038 novel sequence
variants;
(ii) filter for and remove synonymous variants—497 novel se-
quence variants remaining;
(iii) filter for homozygous sequence variants without known
minor allele frequency and not present in the Database of
Single Nucleotide Polymorphisms (dbSNP; http://www.
ncbi.nlm.nih.gov/projects/SNP/)—45 novel sequence var-
iants remaining (Supplementary Table S3). Of these 45
variants, there was only one nonsense mutation—
c.1165A.T predicting p.Lys389∗ inALDH1A3 (transcript
NM_000693.2)—that was verified by Sanger sequencing
(Fig. 2B) and predicted to cause nonsense-mediated
decay and complete absence of protein function. The non-
sense mutation was absent from the Exome Variant Server
(http://evs.gs.washington.edu/EVS/). One hundred and
twenty control chromosomes of diverse ethnicity were
sequenced in view of the Hispanic ethnicity of the
patient, but did not show the nonsense mutation (Coriell
Institute for Medical Research, Multi-Ethnic Panels,
DNA Polymorphism Discovery Resource, http://www.
coriell.org; data not shown). Both parents were heterozy-
gous for the same mutation and an unaffected sibling
was wild-type (Fig. 2B).
Both mutations were predicted to be disease-causing by Muta-
tionTaster (P ¼ 0.99 andP ¼ 0.99 for p.Lys190∗ and p.Lys389∗,
respectively) and to be deleterious by the Protein Variation Effect
Analyzer (PROVEAN), with scores of 21149.97 and 2430.49,
respectively (http://provean.jcvi.org/) (23,24). The nucleotides at
position c.568 and c.1165 were conserved in chimp, rhesus, cat,
mouse and chicken (http://www.mutationtaster.org/).
Antisense morpholino studies targeting the Aldh1a3
ortholog in Danio rerio
We used Danio rerio and antisense morpholinos (MOs) as a
model system to study the effects of loss of function of the ortho-
logous Aldh1a3 gene on eye development. Mutant embryos
Figure1.Pedigree, chromatograms and transpalpebral ultrasonography fromfamily withALDH1A3 loss-of-function mutationp.Lys190∗. (A) Pedigree of family with
two sons affected by A/M. The oldest, III-3, has bilateral anophthalmia and the youngest, III-6, has anophthalmia of the right eye and severe microphthalmia of the left
eye. (B) The chromatogram of the oldest son showing c.568A.T, predicting p.Lys190∗ and premature protein truncation of ALDH1A3. (C) Transpalpebral ultra-
sonography of the right eye of III-3 showed total anophthalmia without cyst. (D) Transpalpebral ultrasonography of the left eye of III-3 showed total anophthalmia
without cyst. (E) Transpalpebral ultrasonography of the right eye of III-6 showed total absence of the eye. (F) Transpalpebral ultrasonography of the left eye of III-6
showed a very small globe with posterior coloboma, detached retina and the presence of the optic nerve in the left orbit.
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injected with 1.5 to 6 ng translational MO or splice MO targeting
the intron 2 exon 2 boundary of D. rerio Aldh1a3 showed a sig-
nificant reduction in eye size relative to wild-type larvae and
control-injected larvae at 48–72 h post-fertilization (h.p.f.; Sup-
plementary Fig. S1), as previously observed by others (25). Add-
itional phenotypes seen with variable penetrance in MO-injected
larvae included delayed closure of the optic fissure, coloboma-
like lesions, cardiac edema and kinking of the tail. We verified
the specificity of the phenotype observed in morphant larvae
and performed rescue experiments by injecting sense mRNA
for the wild-type human ALDH1A3 gene together with transla-
tional MO targeting the D. rerio Aldh1a3 gene (Fig. 3A–D).
Wild-type human ALDH1A3 sense mRNA was able to rescue
the morphant phenotype, but attempted rescue with mutant
human ALDH1A3 sense mRNA containing either the
p.Lys190∗ or the p.Lys389∗ mutations was unsuccessful, as
would be predicted from the likely loss of function caused by
these mutations (Fig. 3E and F). As the clinical phenotype asso-
ciated with ALDH1A3 loss of function includes optic nerve
hypoplasia and ALDH1A3 is known to contribute to the axonal
projections of retinal cells into the brain (26,27), we used
Pou4f3 (previously known as Brn3c) transgenic fish to study
the retinotectal projections of morphant larvae. This transgenic
zebrafish line expresses membrane-targeted green fluorescent
protein (GFP) under the control of the Pou4f3 promoter/enhan-
cer, labeling a subset of retinal ganglion cells that project
into one of the layers of the tectum and into a subset of the
extratectal arborization fields (28). Confocal images of
Pou4f3:mGFP-labeled retinotectal projections of 5 day post-
fertilization (d.p.f.) tecta in live larvae showed that the tectum
from wild-type larvae was filled with retinal axons and the
optic tract had branched into stereotyped fascicles (Fig. 4A),
whereas the tectum from MO-treated larvae appeared less inner-
vated (Fig. 4B).
DISCUSSION
We have demonstrated homozygosity for two nonsense muta-
tions in ALDH1A3, p.Lys190∗ and p.Lys389∗, predicted to be
associated with complete loss of function, in three patients
with bilateral A/M. The absence of ALDH1A3 is predicted to
reduce cellular RA synthesis and thus diminish downstream sig-
naling. Homozygosity for two missense mutations and one splice
Figure2.Chromatograms and the phenotype from a simplex case withALDH1A3 loss-of-function mutation p.Lys389∗. (A) Facial view of the patient (simplex case) at
4 years and 6 months of age, showing bilateral anophthalmia. (B) The chromatogram of the patient (simplex case) showing c.1165A.T, predicting p.Lys389∗ and
premature protein truncation of ALDH1A3. Both parents are heterozygous for the mutation, and an unaffected sibling was wild-type.
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site mutation in ALDH1A3 were previously described in three
patients with A/M (29; for summary of clinical features in all
affected patients to date, see Table 1). Both missense mutations
were shown to result in the loss of ALDH1A3 function (29),
similar to the deficiency of ALDH1A3 predicted by the two non-
sense mutations in this report. It is worth noting that two of the
previously reported patients had optic nerve hypoplasia (29),
as found in the female child in this report. Optic nerve hypoplasia
has been observed inD. reriomodels ofAldh1a3 loss of function
(25), and may prove to be a characteristic phenotypic feature
associated with ALDH1A3 mutations, although it is not specific
for this gene. To date, there is insufficient data to determine the
frequency of ALDH1A3 mutations in human patients with A/M
and whether cardiac defects (for example, the pulmonary valve
stenosis and atrial septal defect seen in one child) (29) will be
observed in other affected individuals. The three patients
described here have no known cardiac defects or neurological
findings, although echocardiograms have not been performed.
The implication ofALDH1A3 loss of function, and thus dimin-
ished RA signaling, in the etiology of human anophthalmia has
been supported by papers on STRA6 loss of function and
animal model studies in mouse and fish. In D. rerio, the ortholo-
gous Aldh1a3 protein shares 70% identity with human
Aldh1a3 protein and 69% nucleotide identity with the human
gene (30). Aldh1a3 expression was detected in the eye from
the 10-somite stage (14 h.p.f.) and is present in the ventral
retina at 24 h.p.f. (30). The high similarity between the human
andD. rerio genes prompted us to use MOs to target the ortholog
of Aldh1a3, and our experiments revealed that the MO-treated
fish had a smaller eye size together with other malformations, in-
cluding cardiac edema and a kinked tail. Similar results, includ-
ing a reduction in eye size, have previously been demonstrated
with MO knockdown of other genes involved in RA metabolism,
including Stra6 (31) and Bcox, an enzyme involved in vitamin
A synthesis (32). Treatment with a RA inhibitor, citral,
at 10–11 h.p.f., resulted in the absence of the ventral retina in
D. rerio (33). The ventral retinal defects could be partially
rescued by RA administration (33). Treatment of D. rerio with
another chemical RA inhibitor, diethylaminobenzaldehyde
(DEAB), at 9 h.p.f. resulted in larvae with microphthalmia,
abnormal retinal development and a reduction in the cell
population and variation in retinal cell-layer lamination (25).
The visual background adaptation and optokinetic responses
were also absent in DEAB-treated embryos (25). The timing of
treatment with RA inhibitors was critical, and paradoxically,
provision of atRA to murine embryos early in development
can result in A/M (33). More widespread phenotypic effects,
including an increase in mortality and cardiac edema, were
also observed in the DEAB-treated fish, thus resembling the
combination of eye and cardiac malformations seen with
STRA6 deficiency in humans and with MO knockdown for
Stra6 in D. rerio (31). Aldh1a3 homozygous null mice have a
lethal phenotype caused by choanal atresia, but also demonstrate
eye defects (26). At E14.5, shortening of the ventral retina, lens
rotation and persistence of the primary vitreous body were
observed, similar to the eye abnormalities in murine embryos
with deficiencies of vitamin A or RA signaling (26,34–36).
The exact pathway in which Aldh1a3 exerts its effects on eye
development has not been fully determined, but aberrant
Wnt signaling has been implicated by several studies. In
Aldh1a12/2/Aldh1a32/2 double-mutant mice, the expression
ofDkk2, a downstream effector ofPitx2 and an antagonist of ca-
nonical Wnt signaling, was markedly reduced at E12.5 in the
perioptic mesenchyme and cornea, suggesting that upregulation
of the Wnt/b-catenin signaling pathway contributed to the eye
defects seen in the double-mutant mice (4). Additionally, the ex-
pression ofAxin2, a gene induced by the Wnt/b-catenin pathway
(37), was increased in the perioptic mesenchyme of the
cornea and the ventral eyelid fold of Aldh1a12/2/Aldh1a32/2
double-mutants at E12.5, also indicative of the upregulation of
Figure 3. Phenotype inD. rerio larvae injected with antisense MO forAldh1a3with rescue experiments. (A) UninjectedD. rerio larva at 24 h.p.f. (B) Representative
D. rerio larva injected with translational antisense MO (ATG-MO) for Aldh1a3 at 24 h.p.f. The eye is reduced in size, edema is present and the tail is shortened. (C)
Representative D. rerio larva injected with control at 24 h.p.f. (D) Representative D. rerio larva injected with translational antisense morpholino (ATG-MO) for
Aldh1a3 together with wild-type human mRNA for ALDH1A3 at 24 h.p.f. Rescue of the morphant phenotype can be observed. (E) Representative D. rerio larva
injected with translational antisense morpholino (ATG-MO) for Aldh1a3 and mutant human mRNA for ALDH1A3/p.Lys190∗ at 24 h.p.f. Rescue of the morphant
phenotype is not observed. (F) Representative D. rerio larva injected with translational antisense morpholino for Aldh1a3 and mutant human mRNA for
ALDH1A3/p.Lys190∗ at 24 h.p.f. Rescue of the morphant phenotype is not observed.
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Wnt/b-catenin signaling (4). Homozygous null mice for Lrp6, a
Wnt co-receptor, exhibit complete loss of Aldh1a1 expression,
and ectopic expression of Adh1a3 showed deregulated RA sig-
naling in early eye development (38). Finally, several putative
TCF/LEF-binding sites were identified in the Aldh1a1 and
Aldh1a3 promoter regions, indicating the possibility of direct
Wnt-mediated regulation of RA synthesis during early eye de-
velopment (38). Alternatively, RA has also been implicated in
forebrain patterning and can act by modulating bone morpho-
genetic protein (BMP) signaling during the presomitic stages
of development and Fibroblast Growth Factor 8 (FGF8) and
Sonic Hedgehog (SHH) signaling during later development (39).
CONCLUSION
We report three children with A/M due to loss-of-function muta-
tions in ALDH1A3. Our findings support the recent implication
of this gene in anophthalmia and severe microphthalmia in
humans. Interestingly, an ocular phenotype with the absence
of the ventral retina associated with RA inhibition in D. rerio
could be partially rescued by provision of vitamin A. Whether
a similar therapeutic approach in human would ameliorate
A/M remains to be seen.
MATERIALS AND METHODS
Exome sequencing
Following informed consent, high-throughput sequencing was
performed in all affected individuals. In the Egyptian family,
whole-exome sequencing was performed on the two affected
individuals after DNA enrichment using an Agilent SureSelect
Human Exon Capture V4 (51 Mbp) kit according to the manu-
facturer’s protocol (Agilent Technologies, Inc., Santa Clara,
CA, USA). DNA sequencing was performed on a HiSeq2000
machine (Illumina, Santa Clara, CA, USA), the data were
uploaded on DNAnexus, mapped to the hg19 reference
genome assembly and the results were viewed with a dedicated
browser. Initial analysis was done examining all reported and un-
reported single-nucleotide polymorphisms (SNPs) to identify
common homozygous regions in the affected brothers that
were not present in their parents. Three regions sized between
2 and 3 Mb and two regions with a size .3 Mb were identified
(Supplementary Table S2). We then searched these regions for
homozygous, non-synonymous or frameshift mutations in the
coding regions of genes.
Whole-genome sequencing
Genotyping was performed in the sporadic case using AxiomTM
Genome-Wide (Human) Array Plates (Affymetrix, Santa Clara,
CA, USA) that contain approximately 700 000 SNPs was per-
formed to detect regions of homozygosity/autozygosity. The
results were analyzed using the Genotyping Console software
(Affymetrix). An amount of 7.5 mg of DNA was submitted for
whole-genome sequencing (Complete Genomics, Inc., Moun-
tain View, CA, USA). The methodology for library preparation,
mapping of reads to the NCBI reference genome (Build 37,
RefSeq accession numbers CM000663–CM000686), local
de novo assembly and protocols for variant-calling have previ-
ously been published (40,41).
Antisense MO injections in D. rerio
The Committee on Animal Research of the University of Cali-
fornia, San Francisco, approved all experiments. Wild-type TL
and AB D. rerio were bred and raised at 28.58C on a 14 h
light, 10 h dark cycle as previously described (42). Antisense
MOs (Gene Tools LLC, Philomath, OR, USA) were designed
to block translation of the D. rerio ortholog of Aldh1a3
(ATG-MO; TATAGTCCCGTTCTGTGCCATAGC) and to
disrupt splicing (Splice-MO; TAGTCAAGTTCCTCTCACTT
TATCC) (43). The Splice-MO targeted the exon 2, intron 2
boundary to disrupt the exon 2 splice donor site, resulting in a
cryptic donor splice site and deletion of the last 20 amino acids
of exon 2. A standard mismatch MO was used as a negative
control. Embryos were microinjected at the 1–4 cell stage
with ATG-MO, Splice-MO or CM at 1.5 to 6 ng/embryo as pre-
viously described (43,44). We assessed survival and toxicity at
24 and 48 h.p.f. to verify the correct dose of MOs (data
not shown). Embryos were de-chorionated and examined at
24–72 h.p.f. for external phenotypes, including eye defects
(microphthalmia, delayed closure of the choroid fissure and
coloboma), cardiac edema, pericardial effusion and tail
kinking. MO-injected larvae were imaged using a Zeiss
Figure 4. Aldh1a3 morphant D. rerio larvae show reduced innervation of the
tectum. (A andB) Confocal images ofPou4f3:mGFP-labeled retinotectal projec-
tions at 5 d.p.f. tecta in live larvae. The wild-type tectum (A) is filled with retinal
axons, and the optic tract has branched into stereotyped fascicles. The
MO-treated tectum (B) appears less innervated. Figures are shown with the anter-
ior aspect of the larvae superiorly. Dotted lines outline the tectal neuropil.
Human Molecular Genetics, 2013, Vol. 22, No. 16 3255
Dissection Scope (Leica 1200; Thornwood, NY, USA) and
camera, and eye size was measured with the ImageJ (http://rsb.
info.nih.gov/ij/) or Leica Application Suite (http://www.
leica-microsystems.com/) software. Eye size for injected
larvae was represented as mean+1 standard deviation and stat-
istical significance was taken as P, 0.05.
To verify Aldh1a3 knock-down after the injection of the
Splice-MO, RNA was extracted from dechorionated embryos
at 30 h.p.f. using TRIzolw (Invitrogen/Life Technologies,
Grand Island, NY, USA) and cDNA was prepared (Superscriptw
III reverse transcriptase; Invitrogen/Life Technologies).
Reverse transcription polymerase chain reaction (PCR) was per-
formed using a standard 30 cycle PCR with a forward primer
(ATGGCACAGAACGGGACTAT) from exon 1 of D. rerio
Aldh1a3 and a reverse primer (ACACCGAGCCTCTCTGACC)
from exon 3 of the same gene (data not shown).
For MO rescue, full-length, sequence-verified human
ALDH1A3 cDNA clones and mutant clones containing
p.Lys190∗ or p.Lys389∗ were obtained (Blue Heron Bio,
Bothell, WA, USA). Capped, sense mRNA was synthesized in
vitro (mMESSAGE mMACHINEw T7 Ultra Kit, Ambion/
Life Technologies) and 75–100 pg mRNA was injected into
each embryo together with translational MO at a dose of
1.5–2 ng. Larvae were dechorionated and examined at
24 h.p.f. by light microscopy. Eye surface area was calculated
and compared between uninjected larvae, larvae injected with
ATG-MO alone, larvae injected with ATG-MO and wild-type
human mRNA for ALDH1A3, larvae injected with ATG-MO
and mutant human mRNA for ALDH1A3/p.Lys190∗ and
larvae injected with ATG-MO and mutant human mRNA for
ALDH1A3/p.Lys389∗.
For live imaging, larvae were treated with 0.003%
1-phenyl-2-thiourea from 22 h.p.f. and embedded in a 0.5 ×
20 mm2 imaging chamber (CoverWell, Grace Bio-labs, Bend,
OR, USA) in 1.2% low-melting-point agarose dissolved in E3
medium (45) containing 0.8% norepinephrine and 0.016% tri-
caine. POU4F3-GFP-expressing larvae were analyzed for
retinal structure and optic nerve projection. Immunofluores-
cence staining was performed after fixation of anesthetized
larvae in 4% paraformaldehyde. Larvae were rehydrated in
phosphate-buffered saline (PBS) and treated with 0.1%
collagenase in PBS to enhance permeability. Incubation times
for 5 d.p.f. was 2 h. We used antibody to GFP (anti-GFP
raised in chick; Sigma-Aldrich, St Louis, MO, USA) at a con-
centration of 1:2000. Secondary antibody AlexaFluor 488 (Invi-
trogen, Carlsbad, CA, USA) was used at a concentration of 1 in
500. Confocal image stacks were acquired using a Zeiss Pascal
laser scanning microscope equipped with×10 and×20 (air, nu-
merical aperture 0.5) and ×40 (water immersion, numerical
aperture 0.8) objectives. To determine axon morphology and ar-
borization, we collected a series of optical planes (z-stack) and
collapsed them into a single image (maximum intensity projec-
tion) or rendered the volume in three dimensions to provide
views of the image stack from different angles. The step size
for each z-stack was chosen upon calculation of the theoretical
z-resolution of the objective used (typically 0.5–1 mm). The
ImageJ plugins StackReg with TurboReg were run with a
macro to correct for translational movement in the image acqui-
sition of the stacks.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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Table 1. Phenotypic features of patients with ALDH1A3 loss-of-function mutations
Phenotypic
feature
Patient IV-1,
Family 1 (29)
Patient IV-5,
Family 1 (29)
Patient IV-1,
Family 2 (29)
Patient 1, Family
3 (29)
Patient III-3,
Family 1 (this
report)
Patient III-6,
Family 1 (this
report)
Patient 3 (this
report)
Eye findings
Anophthalmia +; bilat. +; bilat. +; right eye +; bilat.
Microphthalmia +; bilat. +; bilat. +; bilat. +; left eye
Cysts + + + 2 2 2
ON hypoplasia + + +
OC hypoplasia + + +
Cardiac defect +
Intelligence Autism 3 y ?Autism 4 y Normal Normal Normal Normal
Growth 2nd–10th centile 2nd–9th centile Normal Normal Normal
ALDH1A3
mutation
a
p.Arg89Cys p.Arg89Cys p.Ala493Pro c.475+1G.T p.Lys190∗ p.Lys190∗ p.Lys389∗
ON, optic nerve; OC, optic chiasm; bilat., bilateral; y, years.
aAll mutations are homozygous.
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